Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHL2400227	格隆溴铵新斯的明注射液	glycopyrronium bromide;neostigmine	Injection	Chemical Drugs(3)	Generic Drug	2024-11-15		Nanjing Zenkom Pharmaceutical Co Ltd			view
CYHL2400130	格隆溴铵新斯的明注射液	glycopyrronium bromide;neostigmine	Injection	Chemical Drugs(3)	Generic Drug	2024-06-26		Chengdu Nuohe Shenghong Biopharmaceutical Co Ltd			view
CYHL2300120	格隆溴铵新斯的明注射液	glycopyrronium bromide;neostigmine	Injection	Chemical Drugs(3)	Generic Drug	2023-09-20		Zhejiang Fenghua Pharmaceutical Technology Co Ltd			view
CYHL2200090	格隆溴铵新斯的明注射液	glycopyrronium bromide;neostigmine	Injection	Chemical Drugs(3)	Generic Drug	2022-10-14		Jiangsu Huataichenguang Pharmaceuticals INC			view
CYHL2200089	格隆溴铵新斯的明注射液	glycopyrronium bromide;neostigmine	Injection	Chemical Drugs(3)	Generic Drug	2022-10-14		Nantong No 3 Pharmaceutical Factory			view
CYHL2101022	格隆溴铵新斯的明注射液	glycopyrronium bromide;neostigmine	Injection	Chemical Drugs(3)	Generic Drug	2021-08-10		Reyoung Pharmaceutical Co Ltd			view
CYHL2100018	格隆溴铵新斯的明注射液	glycopyrronium bromide;neostigmine	Injection	Chemical Drugs(3)	Generic Drug	2021-04-02	瑞阳制药股份有限公司	Reyoung Pharmaceutical Co Ltd	In Review	2021-04-01	view
CYHB2400395	格隆溴铵新斯的明注射液	glycopyrronium bromide;neostigmine	Injection	Chemical Drugs(3)	Supplementary Application	2024-03-19					view